TABLE 2.
Serovar
|
Nucleotide
|
Amino acid
|
||||||
---|---|---|---|---|---|---|---|---|
Type | %a | No.b | No. of changes | Changec | omp1 positiond | No. of changes | Changec | MOMP positione |
Ba | 12.9 | 2 | 1 | A → G | 511 (VDII) | 1 | S → G | 171 |
2 | 2 | A → G | 511 (VDII) | 2 | S → G | 171 | ||
C → T | 662 (CD) | P → L | 221 | |||||
C | 87.1 | 26 | 4 | T → C | 569 (CD) | 3 | I → T | 190 |
A → G | 571 (CD) | N → D | 191 | |||||
G → A | 972 (VDIV) | Silent | ||||||
G → T | 1003 (VDIV) | A → S | 335 | |||||
1 | 5 | T → C | 569 (CD) | 4 | I → T | 190 | ||
A → G | 571 (CD) | N → D | 191 | |||||
A → G | 697 (CD) | N → D | 233 | |||||
G → A | 972 (VDIV) | Silent | ||||||
G → T | 1003 (VDIV) | A → S | 335 |
Percentage of 31 C. trachomatis PCR-amplified conjunctival samples with the indicated serovar.
Number of C. trachomatis samples having the same omp1 sequence changes as those indicated.
Nucleotide and amino acid changes from the most phylogenetically related reference strain (i.e., Ba/Apache-2 and C/TW-3/OT).
Nucleotide position from the start of the C. trachomatis omp1 gene at which the change was located.
Amino acid position from the start of the MOMP at which the deduced change has occurred.